ホーム › 前立腺がん › ウィスコンシン › Milwaukee
Milwaukee、WIにおける前立腺がんの臨床試験
Milwaukeeとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
被験者募集中第3相
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
- Medical College of Wisconsin, Milwaukee
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5マイル先
- 他6件
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11マイル先
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11マイル先
- 他1件
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 他9件
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
被験者募集中第2相
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11マイル先
- Froedtert Menomonee Falls Hospital, Menomonee Falls · 14マイル先
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
被験者募集中第2相
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 他7件
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
被験者募集中第3相
- Medical College of Wisconsin ( Site 0020), Milwaukee
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
被験者募集中第2/3相
- Medical College Of Wisconsin, Milwaukee
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- Medical College of Wisconsin ( Site 0008), Milwaukee
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
被験者募集中第3相
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- 他8件
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
被験者募集中第2相
- Froedtert & the Medical College of Wisconsin, Milwaukee
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Zablocki Veterans Administration Medical Center, Milwaukee
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
被験者募集中第1相
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
被験者募集中
- Froedtert Hospital, Milwaukee
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
被験者募集中第1相
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
被験者募集中第1相
- Medical College of Wisconsin, Milwaukee
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
被験者募集中第2/3相
- Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
被験者募集中観察研究
- Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Milwaukee
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
- Zablocki Veterans Administration Medical Center, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11マイル先
- 他1件
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN42件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Milwaukeeにおける他の研究
- 乳がん23件の研究
- 非小細胞肺癌22件の研究
- がん（全種類）22件の研究
- 肺がん21件の研究
- 多発性骨髄腫21件の研究
- 濾胞性リンパ腫19件の研究
- 膵臓がん18件の研究
- 非ホジキンリンパ腫18件の研究
- 卵巣がん17件の研究
- 急性骨髄性白血病17件の研究
- バーキットリンパ腫16件の研究
- 心不全16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。